It is sad to see pets die of something easily preventable. It's even worse knowing that the owner was misinformed or misled ...

Sutter Health has agreed to pay about $230 million to settle a federal class-action lawsuit accusing it of anticompetitive ...

The Belgian antitrust regulator sanctioned some of the largest purveyors of over-the-counter medicines, the latest effort by ...

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...

The NIH announced six acting directors to run institutes, many to fill vacancies created by the ouster of predecessors ...

Amid growing anxiety over tariffs, one medical center has warned its suppliers that any sudden price hikes attributed to the ...

A spokesperson said Thursday that "NIH initially exceeded its internal targets for contract reductions" in explaining the ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Trump's second term is playing out a lot differently than health care companies and their lobbyists hoped for.

In today's Morning Rounds newsletter, HHS axes an autism registry, the Trump presidency approaches 100 days, and funding for ...

A federal health study that was examining the high burden of chronic disease in rural areas learned its funding has been cut off.

Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data ...